Biomarkers – Products

New comprehensive biomarker panels equip physicians with clinically actionable insights for earlier, more accurate diagnosis.

Strategic collaborations in molecular residual disease monitoring of cancer and product launches in ddPCR portfolio advance corporate strategy in H1 2024.

Expansion of metabolite identification database accelerates insights, translation of findings for small molecule biomarker studies.

Your single solution for multimodal data​.
Uncover a true 6-base genome for unprecedented insights into current and future biological states. Access all four canonical bases and distinguish 5‑methylcytosine (5mC) and 5‑hydroxymethylcytosine (5hmC) from a single 5ng DNA sample, in a single experiment, with high accuracy.

Maximize rare variant detection with Twist's cfDNA Library Preparation Kit. Up 2X conversion yield of cfDNA libraries, high coverage libraries and robust performance, even with minimal sample input enables the confidence you value.

Leica Microsystems, has released version 14 of Aivia, its flagship image analysis solution. This update introduces a suite of new features and enhancements for accurate deep-learning based cell segmentation.

AMP published a set of evidence-based recommendations for the analytical validation and reporting of tumor mutational burden (TMB) testing as a potential predictive biomarker for immune checkpoint inhibitor (ICI) therapies.

At ASMS 2024, SCIEX, introduces ZT Scan DIA for LC-MS/MS, the next generation in data-independent acquisition (DIA) that leverages the combination of the quadrupole dimension with the rich MS2 data attainable from the Zeno trap.

At the 72nd ASMS meeting, Bruker Corporation (Nasdaq: BRKR) launches the new top-of-the-line timsTOF Ultra 2 system with significantly further enhanced sensitivity for deep profiling of small cells and subcellular organelles.

New analytical instruments and workflow capabilities improve productivity, reliability and sensitivity of discovery, translational and clinical research.